Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Novasep Upgrades API Manufacturing Facility | Contract Pharma

What are you searching for?

Sign in
Breaking News

Novasep Upgrades API Manufacturing Facility

A $7.3 million investment will be made over 3 years to modernize the Mourenx site.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Novasep, a supplier of services and technologies for the life sciences industry, is investing $7.3 million at its Mourenx site in France to modernize the API manufacturing facility.
 
Upgrades to this cGMP workshop include the installation of new equipment and the revamping of clean rooms for API isolation. This project will enhance Novasep’s flexibility and develop a high-performance capacity for the custom manufacturing of innovative therapeutic molecules, in accordance with the highest quality and safety requirements and with improved environmental protection. To accompany this investment, Novasep also announced the creation of 7 full-time jobs on this site.
 
This project has been selected as part of the France Relance recovery plan initiated by the French government. Novasep will be supported within the framework of the “Investissements d’Avenir” (Investments for the future) program which rewards innovative and promising industrial investments, in order to allow France to increase its economic growth and employment potential.
 
“This investment sends a strong signal to our customers and partners by increasing our market competitiveness,” said Michel Spagnol, chairman and CEO, Novasep. “It further supports our strategy of reinforcing our high-quality offer for the commercial production of innovative therapies. I am proud of this investment which contributes to manufacturing jobs in France and allows us to further develop our activity in the Aquitaine region.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics